Antibodies that immunospecifically bind to B lymphocyte stimulator protein
The present invention relates to antibodies and related molecules that immunospecifically bind to B Lymphocyte Stimulator. The present invention also relates to methods and compositions for detecting or diagnosing a disease or disorder associated with aberrant B Lymphocyte Stimulator expression or inappropriate function of B Lymphocyte Stimulator comprising antibodies or fragments or variants thereof or related molecules that immunospecifically bind to B Lymphocyte Stimulator. The present invention further relates to methods and compositions for preventing, treating or ameliorating a disease or disorder associated with aberrant B Lymphocyte Stimulator expression or inappropriate B Lymphocyte Stimulator function comprising administering to an animal an effective amount of one or more antibodies or fragments or variants thereof or related molecules that immunospecifically bind to B Lymphocyte Stimulator.
1. An isolated polynucleic acid encoding an antibody or fragment thereof that immunospecifically binds to B Lymphocyte Stimulator protein comprising a first, second and third nucleic acid sequence, where the first nucleic acid sequence encodes a variable heavy chain domain (VH) that is at least 95% identical to the VH domain of the scFv of SEQ ID NO:327, the second nucleic acid sequence encodes a variable light chain domain (VL) that is at least 95% identical to the VL domain of the scFV of SEQ ID NO:327 and the third nucleic acid sequence encodes a heterologous amino acid linker, wherein the first and second nucleic acid sequences of the antibody or fragment thereof are joined together by the third nucleic acid sequence.
2. The isolated polynucleic acid of claim 1 wherein the first nucleic acid encodes an amino acid sequence that is identical to the VH domain of the scFv of SEQ ID NO:327.
3. The isolated polynucleic acid of claim 1 wherein the second nucleic acid encodes an amino acid sequence that is identical to the VL domain of the scFv of SEQ ID NO:327.
4. The isolated polynucleic acid of claim 1 wherein the first nucleic acid encodes an amino acid sequence that is identical to the VH domain of the scFv of SEQ ID NO:327 and the second nucleic acid encodes an amino acid sequence that is identical to the VL domain of the scFv of SEQ ID NO:327.
5. The isolated polynucleic acid of claim 1 wherein the B Lymphocyte Stimulator is selected from the group consisting of: (a) a protein whose amino add sequence consists of amino acid residues 1-285 of SEQ ID NO:3228; (b) a protein whose amino acid sequence consists of amino add residues 134-285 of SEQ ID NO:3228; and (c) a trimer of the protein of (b).
6. An isolated cell comprising the isolated polynucleic acid of claim 1 .